Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Aebi

Showing results (41-50 of 71) with videos related to

Pageof 8
Sort By:
British Journal of Cancer|March 26, 1998
The effect of different chemotherapeutic agents on the enrichment of DNA mismatch repair-deficient tumour cellsD Fink, S Nebel, P S Norris, et al.
British Journal of Cancer|January 1, 1997
Expression of the DNA mismatch repair proteins hMLH1 and hPMS2 in normal human tissuesD Fink, S Nebel, S Aebi, et al.
Cancer Research|November 1, 1996
The role of DNA mismatch repair in platinum drug resistanceD Fink, S Nebel, S Aebi, et al.
Genomics|September 15, 1996
Isolation of the ATP-binding human homolog of the arsA component of the bacterial arsenite transporterB Kurdi-Haidar, S Aebi, D Heath, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 20, 2004
Capecitabine and vinorelbine in elderly patients (> or =65 years) with metastatic breast cancer: a phase I trial (SAKK 25/99)D Hess, B Thürlimann, O Pagani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
all-trans retinoic acid enhances cisplatin-induced apoptosis in human ovarian adenocarcinoma and in squamous head and neck cancer cellsS Aebi, R Kröning, B Cenni, et al.
British Journal of Cancer|June 9, 1999
Loss of DNA mismatch repair facilitates reactivation of a reporter plasmid damaged by cisplatinB Cenni, H K Kim, G J Bubley, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
Prevalence of functional iron deficiency in patients with malignancies and its impact on fatigue-specific quality of lifeS Zimmermann, S Aebi, O Gautschi, et al.
Oncology|January 11, 2001
Activity of gemcitabine and continuous infusion fluorouracil in advanced pancreatic cancerD P Rauch, C A Maurer, S Aebi, et al.
Cancer Research|August 1, 1997
Differential induction of c-Jun NH2-terminal kinase and c-Abl kinase in DNA mismatch repair-proficient and -deficient cells exposed to cisplatinA Nehmé, R Baskaran, S Aebi, et al.
Pageof 8

Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
British Journal of Cancer|March 26, 1998
The effect of different chemotherapeutic agents on the enrichment of DNA mismatch repair-deficient tumour cellsD Fink, S Nebel, P S Norris, et al.
British Journal of Cancer|January 1, 1997
Expression of the DNA mismatch repair proteins hMLH1 and hPMS2 in normal human tissuesD Fink, S Nebel, S Aebi, et al.
Cancer Research|November 1, 1996
The role of DNA mismatch repair in platinum drug resistanceD Fink, S Nebel, S Aebi, et al.
Genomics|September 15, 1996
Isolation of the ATP-binding human homolog of the arsA component of the bacterial arsenite transporterB Kurdi-Haidar, S Aebi, D Heath, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 20, 2004
Capecitabine and vinorelbine in elderly patients (> or =65 years) with metastatic breast cancer: a phase I trial (SAKK 25/99)D Hess, B Thürlimann, O Pagani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
all-trans retinoic acid enhances cisplatin-induced apoptosis in human ovarian adenocarcinoma and in squamous head and neck cancer cellsS Aebi, R Kröning, B Cenni, et al.
British Journal of Cancer|June 9, 1999
Loss of DNA mismatch repair facilitates reactivation of a reporter plasmid damaged by cisplatinB Cenni, H K Kim, G J Bubley, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
Prevalence of functional iron deficiency in patients with malignancies and its impact on fatigue-specific quality of lifeS Zimmermann, S Aebi, O Gautschi, et al.
Oncology|January 11, 2001
Activity of gemcitabine and continuous infusion fluorouracil in advanced pancreatic cancerD P Rauch, C A Maurer, S Aebi, et al.
Cancer Research|August 1, 1997
Differential induction of c-Jun NH2-terminal kinase and c-Abl kinase in DNA mismatch repair-proficient and -deficient cells exposed to cisplatinA Nehmé, R Baskaran, S Aebi, et al.
Pageof 8